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Cell-mediated autoimmunity, particularly that involving autoreactive T cells, participates in mediating anti-glomerular base-
ment membrane (GBM) disease. However, direct kidney injury mediated by renal infiltrated T cells has not been clearly eluci-
dated in humans. The T cell profile (CD3, CD4, CD8, IL-17, and foxp3) and macrophage (CD68) were examined by immuno-
histochemistry on renal biopsy tissues from 13 patients with anti-GBM disease. The correlation between cell infiltration and 
clinical data was also analyzed. We found that the distribution of T cell infiltration was predominant in the peri-glomerular and 
interstitial areas. CD3+ T cell infiltratrion around the glomeruli with cellular crescent formations was significantly higher than 
that around the glomeruli with mild mesangial proliferation. CD8+ T cells significantly accumulated around the glomeruli with 
cellular crescents without IgG deposits compared to those with IgG deposits. The prevalence of infiltrating CD8+ T cells was 
correlated with the percentage of ruptured Bowman’s capsules. In conclusion, cellular immunity may play a crucial role in the 
inflammatory kidney injury in anti-GBM patients. The periglomerular infiltration of T cells, especially CD8+ T cells, may par-
ticipate in the pathogenic mechanism of glomerular damage. 
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Anti-glomerular basement membrane (GBM) disease is an 
autoimmune disorder characterized by rapidly progressive 
glomerulonephritis and is often accompanied by lung hem-
orrhage (Kalluri, et al., 1995). Although the pathogenic 
roles of anti-GBM autoantibodies against the non-     
collagenous domain 1 of 3 chain of type IV collagen 
(3(IV)NC1) have been fully demonstrated (Sado et al., 
1989; Wilson and Dixon, 1973), there is strong evidence 
indicating that the full expression of this disease is depend-
ent on cell-mediated autoimmunity, particular autoreactive 
T cells.  
In rodent models, 3(IV)NC1-specific CD4+ T cells 
alone are sufficient to induce glomerular injury in the  
absence of autoantibodies against GBM, revealing a direct 
pathogenic role (Wu et al., 2002). The disease cannot  
be induced in CD4+ and CD8+ T cell knockout mice  
(Tipping et al., 1998) and is inhibited by CD28-B7 and 
CD154-CD40 co-stimulatory blockades (Reynolds et al., 
2000, 2004) as well as anti-CD8 monoclonal antibodies 
(Reynolds et al., 2002). Additionally, a Th17 cell subset, 
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which is maintained by IL-23, plays a dominant role in the 
development of anti-GBM disease. IL-23-deficient mice 
immunized with 3(IV)NC1 may develop anti-GBM dis-
ease. While the autoantibody titers are lower in these mice, 
cellular reactivity is reduced and renal injury is less severe 
than that in non-IL-23-deficient mice (Ooi et al., 2009). In 
human anti-GBM disease, T cell involvement can be im-
plied from strong human leukocyte antigen (HLA) associa-
tions (Phelps and Rees, 1999). CD4+ and CD8+ T cell  
infiltration has been observed in the affected glomeruli 
(Bolton et al., 1987). However, the contributions of T cell 
infiltration to kidney injury in humans remain unclear.  
In the current study, we detected different types of T 
cells and macrophages in the renal biopsy tissues from an-
ti-GBM patients. We analyzed the associations between the 
infiltrating cells in different areas and the corresponding 
clinical and pathological data to elucidate the role of infil-
trated T cells in the development of kidney injury in patients 
with anti-GBM disease.  
RESULTS 
Clinical features and pathological data of patients 
Thirteen patients with biopsy-proven anti-GBM disease 
were enrolled in this study. Patients with positive an-
ti-neutrophil cytoplasmic antibody (ANCA) or secondary 
anti-GBM disease were excluded. The demographic data 
and clinical features are shown in Table 1. At the time of 
diagnosis, the mean concentration of serum creatinine was 
(907.7±339.0) μmol L1. All patients underwent a kidney 
biopsy, and were diagnosed as crescentic glomerulonephri-
tis for large crescent formation in over 50% of glomeruli by 
light microscopy and confirmed by electron microscopy. 
The mean percentage of crescents in glomeruli was 
(93.8±9.0)%. As measured by direct immunofluorescence, 
61.5% of the patients exhibited linear IgG deposition along 
the GBM, with or without C3 deposits. All patients pos-
sessed circulating anti-GBM IgG antibodies at an average 
level of (76.2±42.2) U mL1, which was confirmed by en-
zyme-linked immunosorbent assay (ELISA) using recom-
binant human 3(IV)NC1. During the 1-year follow-up, 
79.6% of the patients were alive, but all patients had pro-
gressed to end stage renal disease (ESRD). 
T cell and macrophages infiltration in the kidneys 
Positive staining for CD3+, CD4+, CD8+, IL-17-producing, 
foxp3+, and CD68+ cells were detected in the kidney tissues 
of all patients (Figure 1). CD3+ cells infiltration was more 
common than macrophages infiltration (Table 1). Inside the 
glomeruli with crescents, macrophages were detected at a 
higher frequency than T cells. Outside the glomeruli in the 
periglomerular and interstitial areas, T cells infiltrated more 
predominantly than macrophages. T cell infiltration, in-
cluding the CD3+, CD8+, CD4+, and IL-17-producing cells, 
exhibited differential distributions in the kidney, with pre-
dominance in the periglomerular area, followed by the in-
terstitial area and then the intraglomerular area (Table 2). 
Foxp3+ cells were detected only in the interstitial area and 
not in the intra- or periglomerular areas. No significant dif-
ferences were observed in the distributions of macrophages 
in the different areas of the kidney (Table 2).  
 
 
Figure 1  T cell and macrophage infiltration in the kidney tissues of pa-
tients with anti-GBM disease. Immunohistochemistry + PAS, magnifica-
tion 400×, ↑positive cells in peri-glomerular area, ↑↑positive cells in 
intraglomerular area. A, CD3+ cells infiltrated in the peri-glomerular area. 
B, CD3+ cells in the interstitial area. C, CD4+ cells infiltrated in the pe-
ri-glomerular area. D, CD4+ cells in the interstitial area. E, CD8+ cells 
infiltrated in the peri-glomerular area. F, CD8+ cells in the interstitial area. 
G, IL-17+ cells infiltrated in the peri-glomerular area. H, IL-17+ cells in the 
interstitial area. I, CD68+ cells infiltrated in the intra-glomerular area. J, 
CD68+ cells in the interstitial area. 
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Table 1  Demographics, clinical parameters and outcomes of patients 
with anti-GBM disease 
Parameter  N=13 
Age (year) 30.5±11.8 
Gender (male/female) 9/4 
Prodromal infection, n (%) 5 (38.5) 
Hydrocarbon exposure, n (%) 1 (7.7) 
Smoking, n (%) 7 (53.8) 
Hemoptysis, n (%) 7 (53.8) 
Hemoglobin (g L1) 75.2±19.9 
Oliguria/anuria, n (%) 5 (38.5) 
Urinary protein (g 24 h1) 5.3±4.1 
Nephrotic syndrome, n (%) 6/8 (75.0) 
Gross hematuria, n (%) 5 (38.5) 
Serum creatinine on diagnosis (μmol L1) 907.7±339.0 
Level of anti-GBM antibodies (U mL1) 76.2±42.2 
Percentage of crescents in glomeruli 93.8±9.0 
Cellular crescents  66.2±31.8 
Fibro-cellular crescents  28.6±24.0 
Fibrotic crescents 5.2±15.2 
Cells infiltration in kidneys  
CD3 positive cells (cells mm2) 1776.4±1209.0 
CD4 positive cells (cells mm2) 268.8±234.0 
CD8 positive cells (cells mm2) 610.8±484.2 
IL-17 positive cells (cells mm2) 180.9±39.1 
Foxp3 positive cells (cells mm2) 7.0±7.1 
CD68 positive cells (cells mm2) 993.9±628.2 
Renal survival at one year, n (%) 0/13 (0) 
Patient survival at one year, n (%) 10/13 (76.9) 
 
The association between cell infiltration and crescent 
formation 
Crescent formation is a classical glomerular injury in an-
ti-GBM disease. Following kidney injury, crescents present 
as cellular, fibrocellular, or fibrous crescents. 
The infiltration of CD3+ T cells was more severe around 
the glomeruli with cellular crescents than those with mild 
mesangial proliferation ((11.3±8.4) vs. (3.5±2.1) cells gcs1, 
P=0.040). The infiltration of CD4+ T cells around the glo-
meruli with cellular crescents was positively correlated with 
the serum creatinine level on diagnosis (r=0.786, P=0.021) 
(Figure 2).  
The number of IL-17-producing cells that infiltrated 
around the glomeruli with fibrocellular crescents was sig-
nificantly higher than that with mild mesangial proliferation 
((1.28±0.58) vs. 0 cells gcs1, P=0.032). The number of 
infiltrating IL-17-producing cells in the glomeruli with cel-
lular crescents was positively correlated with the percentage 
of cellular crescents in the glomeruli (r=0.968, P=0.007). 
The correlation between cell infiltration and IgG deposi-
tion in kidneys 
Linear IgG deposition along the GBM was observed in the 
renal biopsies of 61.5% of the patients; however, all patients 
presented circulating antibodies against human 3(IV)NC1. 
No significant differences in the clinical data and kidney 
injuries were observed between the patients with and with-
out IgG deposition (Table 3). However, cell infiltration in 
the kidneys was different. When compared with the patients 
with classical IgG deposition on the GBM, the patients 
lacking IgG deposition showed significantly more T cell 
infiltration in the interstitial area of the kidney 
((786.0±316.2) vs. (305.0±196.3) cells mm2, P=0.017) 
(Figure 3A) and more CD8+ T cells in the glomerular area 
(i.e., the intra- and periglomerular areas) with cellular cres-
cents ((10.7±6.4) vs. (1.1±1.0) cells gcs, P=0.027) (Figure 
3B). No correlation was found between circulating an-
ti-GBM antibodies and infiltrating T cells. 
The association between cell infiltration and the rupture 
of Bowman’s capsule 
The rupture of Bowman’s capsule represents severe damage 
of the glomerulus. Much more T cells were observed in the 
interstitial area around the glomeruli with ruptureed Bow- 
 
 
Figure 2  The correlation between the number of CD4+ cells in the peri-
glomerular area with cellular crescent and the level of serum creatinine at 
diagnosis. 
Table 2  Cell infiltration in the intra-glomerular, peri-glomerular, and interstitial areas of the kidneys of patients with anti-GBM disease 






(cells mm2) P value 
CD3+ 6.6±3.3 43.6±42.8 1317.6±1033.7 497.4±341.2 0.001 
CD4+ 7.4±4.5 1.7±4.8 176.3±162.4 119.4±121.2 0.021 
CD8+ 5.7±2.6 13.9±14.6 456.4±391.7 161.4±118.4 0.002 
IL-17+ 6.2±2.9 10.5±13.0 114.5±54.4 67.1±54.5 0.004 
Foxp3+ 7.6±3.5 0 0 7.0±7.1 0.028 
CD68+ 6.3±1.5 119.7±21.1 661.6±598.6 186.7±56.8 0.143 
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Figure 3  The differences in cell infiltration numbers between patients 
with IgG deposition in kidneys and those without IgG deposition. A, More 
CD3+ cells infiltrated in the interstitial area of the kidneys with IgG linear 
deposition than those lacking the deposition ((786.0±316.2) vs. (305.0± 
196.3) cells mm2, P=0.017). B, More CD8+ T cells in the glomerular area 
of cellular crescents were observed in the kidneys with IgG linear deposi-
tion than those without IgG deposits ((10.7±6.4) vs. (1.1±1.0) cells gcs1, 
P=0.027). 
man’s capsule. The number of T cells in the interstitial area 
was positively correlated with the percentage of glomeruli 
with ruptured Bowman’s capsules (r=0.709, P=0.022) (Fig-
ure 4A). When compared with the glomeruli with intact 
Bowman’s capsules, the glomeruli presenting with ruptured 
Bowman’s capsules had significantly higher numbers of 
CD8+ cytotoxic T cells infiltrating the glomerular area (i.e., 
the intra- and peri-glomerular areas) ((9.0±6.8) vs. (2.7±2.0) 
cells gcs, P=0.040) (Table 4). Furthermore, the number of 
infiltrating CD8+ T cells in the glomerular area was posi-
tively correlated with the percentage of glomeruli with rup-
tured Bowman’s capsule (r=0.708, P=0.022) (Figure 4B). 
The number of IL-17-producing cells was also significantly 
higher in the glomerular area of the glomeruli with ruptured 
Bowman’s capsules than those with intact capsules 
((2.1±1.3) vs. (0.5±0.3), P=0.016) (Table 4).  
DISCUSSION 
In the current study, we identified remarkable T cell infil-
tration in the kidneys of patients with anti-GBM glomeru-
lonephritis. CD8+ and IL-17+ cells were the most predomi-
nant subtypes and were closely associated with damage to 
the glomerular structures. This study first identified the in-
filtration of IL-17-producing cells in the kidneys in human 
anti-GBM disease. More severe T cell infiltration was ob-
served in the kidneys without IgG deposits, highlighting the 
pathogenic role for these autoreactive T cells.  
T cells were predominantly distributed in the periglom-   
Table 3  Demographics, clinical parameters and outcomes of anti-GBM patients, with comparison between patients having IgG linear deposits on GBM 
and those without deposits 
Parameter  IgG deposit positive N=8 IgG deposit negative N=5 P value 
Age (year) 28.8±12.4 33.4±11.9 0.522 
Gender (male/female) 6/2 3/2 1.000 
Prodromal infection, n (%) 1 (12.5) 4 (80) 0.032 
Hydrocarbon exposure, n (%) 0 1 (20) 0.385 
Smoking, n (%) 4 (50) 3 (60) 1.000 
Hemoptysis, n (%) 5 (62.5) 2 (40) 0.592 
Hemoglobin (g L1) 77.9±23.8 71.0±12.5 0.567 
Oliguria/anuria, n (%) 2 (25) 3 (60) 0.293 
Urinary protein (g 24 h1) 6.0±4.5 4.3±3.7 0.532 
Nephrotic syndrome, n (%) 4/6 (66.7) 2/2 (100) 1.000 
Gross hematuria, n (%) 2 (25) 3 (60) 0.293 
Serum creatinine on diagnosis (μmol L1) 1038.3±337.7 698.8±237.8 0.077 
Level of anti-GBM antibodies (U mL1) 67.2±44.5 90.6±38.3 0.351 
Percentage of crescents in glomeruli 96.6±5.1 89.4±12.4 0.273 
Cellular crescents  59.5±26.5 76.8±39.6 0.362 
Fibro-cellular crescents  33.8±16.5 20.4±33.5 0.352 
Fibrotic crescents 6.9±19.1 2.8±6.3 0.667 
Renal survival at one year, n (%) 0/8 (0) 0/5 (0) 
Patient survival at one year, n (%) 6/8 (62.5) 4/5 (80) 1.000 
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Figure 4  The relationship between cell infiltration and the percentage of 
ruptured Bowman’s capsules. A, The number of T cells in the interstitial 
area was positively correlated with the percentage of glomeruli with a 
ruptured Bowman’s capsule (r=0.709, P=0.022). B, The number of CD8+ T 
cells in the glomerular area was positively correlated with the percentage 
of glomeruli with ruptured Bowman’s capsule (r=0.708, P=0.022). 
Table 4  Kidney infiltration of T cells and macrophages with and without 
ruptured Bowman’s capsule in patients with anti-GBM diseasea) 
Marker iBC (cells gcs1) rBC (cells gcs1) P 
CD3+    
Intraglomerular area 0.4±0.5 1.0±1.1 0.127 
Periglomerular area 15.3±23.0 16.7±11.3 0.121 
Glomerular area 15.7±23.0 17.7±12.1 0.131 
CD8+    
Intraglomerular area 0.1±0.1 0.4±0.3 0.031 
Periglomerular area 2.6±2.0 8.6±6.8 0.063 
Glomerular area 2.7±2.0 9.0±6.8 0.040 
CD4+    
Intraglomerular area 0.0±0.1 0.5±1.4 1.000 
Periglomerular area 1.6±1.8 3.3±2.9 0.210 
Glomerular area 1.6±1.9 3.8±3.9 0.200 
IL-17+    
Intraglomerular area 0.1±0.2 0.4±0.8 0.295 
Periglomerular area 0.4±0.4 1.6±0.9 0.036 
Glomerular area 0.5±0.3 2.1±1.3 0.016 
CD68+    
Intraglomerular area 1.5±0.9 2.6±0.6 0.268 
Periglomerular area 3.0±3.5 10.1±9.7 0.248 
Glomerular area 4.7±2.5 12.7±10.2 0.379 
a) iBC, intact Bowman capsule. rBC, ruptured Bowman capsule. gcs, 
glomerular cross-section. 
erular and interstitial areas, especially around severely in-
jured glomeruli with crescent formation or a ruptured 
Bowman’s capsule. Rutgers et al. also observed that vascu-
litis patients with periglomerular granulomatous inflamma-
tion presented with higher proteinuria and higher activity 
index scores (Rutgers et al., 2005). These findings indicate 
that T cell stimulation participates in damaging the kidney 
structure in human anti-GBM disease.  
The first mechanism for the pathogenic role of T cells in 
kidney injury may be mediated by CD4+ helper T cells. We 
found that the infiltration of CD4+ cells was much higher in 
the areas around the glomeruli with crescents and were pos-
itively correlated with serum creatinine levels. Previous 
studies have implied that glomerular-derived antigenic pep-
tides that enter the urine can be captured and degraded by 
tubular cells and subsequently presented to interstitial den-
dritic cells, leading to the stimulation of infiltrating T cells 
(Wilde et al., 2009; Krüger et al., 2004; Macconi et al., 
2009). However, the dendritic cells in the interstitia do not 
natively recognize autoantigens on the GBM. Other resident 
glomerular cells may have more significant roles in the ac-
tivation of T cells around the glomeruli. Recent studies have 
indicated that podocytes from parietal epithelial cells were 
the predominant cellular components of crescents (Appel et al., 
2009); these podocytes function as local professional anti-
gen-presenting cells in the kidney (Goldwich et al., 2013) 
and may destroy its structure (Li et al., 2015). Further stud-
ies are required to determine the mechanisms of interaction 
between T cells and podocytes to elucidate the activation of 
CD4+ cells in the kidney in situ. 
The second mechanism of kidney structure damage may 
be directly mediated by CD8+ effector T cells. This is sup-
ported by the close association between CD8+ T cell infil-
tration around the glomeruli and the rupture of the Bow-
man’s capsule, as observed in the current study. Such rup-
turing of the capsule results in the release of glomerular 
antigens to the intersititia, which initiates a positive feed-
back cycle involving antigen capture and presentation by 
renal dendritic cells to the Th cells, the subsequent produc-
tion of chemokines and cytokines, the recruitment of addi-
tional CD8+ T cells and macrophages, and aggravated renal 
damage. The rupture of the Bowman’s capsule may also 
facilitate the entry of these activated periglomerular T cells 
and fibroblasts into the Bowman’s space, enabling crescent 
formation and a progressive fibrous organization of cellular 
crescents (Boucher et al., 1987).  
This study was the first to investigate IL-17+ cells in hu-
man anti-GBM disease patients. We provided evidence of 
IL-17+ cell infiltration in the kidneys. The IL-17+ cells were 
observed more frequently than CD4+ T cells in the glomer-
ular area, indicating that other IL-17-expression cells such, 
as  T cells, neutrophils, and mast cells, may participate in 
local inflammation (Velden et al., 2012). IL17-producing 
Th17 cells accounted for much of the T cell-induced in-
flammation (Miossec et al., 2009; Kitching and Holdsworth, 
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2011). The presence of Th17 cells has been demonstrated in 
inflamed kidneys, and the IL23/Th17 axis is considered 
central to the mediation of kidney injury in anti-GBM mod-
els (Ooi et al., 2009). Paust et al. provided mechanistic evi-
dence for a cytokine–chemokine-driven feedback loop that 
orchestrated the differential Th1 and Th17 cell infiltrations 
into inflamed kidneys (Paust et al., 2005). A recent study 
found that renal  Tcell was the major source of IL-17 in 
experimental cresentic glomerulonephritis and promoted 
kidney injury through IL-23 mediated neutrophil recruit-
ment (Turner et al., 2012). All of the above findings high-
light the crucial role of IL-17-producing cells in the patho-
genesis of kidney injury in human anti-GBM disease.  
In the current study, nearly forty percent of the patients 
with positive serologic anti-GBM autoantibodies lacked IgG 
deposition along the GBM in the kidney. Several mecha-
nisms have been suggested for the absence of antibody de-
tection (Cui et al., 2005; Sheerin et al., 2001); however, the 
mechanism of crescent formation without antibody deposi-
tion was unclear. We observed that in the kidneys without 
IgG deposition, more T cell infiltration was detected than in 
the kidneys with antibody deposition. In rodent models of 
anti-GBM nephritis, nearly half of the rats immunized with 
rCol43NC1 developed severe glomerulonephritis and 
lacked IgG deposition in the kidneys (Wu et al., 2001). 
rCol43NC1-specific T cells have been identified as having 
a direct pathogenic role in initiating glomerular injury in the 
absence of autoantibodies (Wu et al., 2002). The therapeutic 
intervention by the depletion of CD8+ cells using monoclo-
nal antibodies could block crescent formation and glomeru-
lonephritis development in the models without significantly 
affecting the circulating levels of antibodies (Reynolds et al., 
2002; Kawasaki et al., 1992). These findings imply that 
autoreactive T cells might lead to crescent formation with-
out the need of autoantibodies.  
A few unique features of the T cell response to GBM in-
clude the appearance of long-living Tregs and the inversion 
of T cell effector/regulatory cell ratios in later stages of the 
disease in animal models (Wolf et al., 2005; Ooi et al., 
2011; Tan et al., 2013). These features may account for the 
uncommon recurrences of anti-GBM disease compared with 
other autoimmune glomerulonephritis (Wolf et al., 2005; 
Ooi et al., 2011; Tan et al., 2013). In this study, few Tregs 
were observed in the kidney. This may be due to severe the 
kidney damage and active disease profile in our patients.  
In conclusion, cellular immunity may play a crucial role 
in the inflammatory kidney injury of anti-GBM patients. 
The periglomerular and interstitial infiltrations of T cells, 
especially CD8+ T cells, likely participate in the pathogenic 
mechanisms of glomerular damage in anti-GBM disease. 
MATERIALS AND METHODS 
Patients 
Renal biopsy samples from 13 patients with biopsy-proven  
anti-GBM disease were collected at Peking University First 
Hospital. All patients were positive for serum anti-GBM 
autoantibodies as determined by commercial ELISA kits 
(Euroimmun, Germany) using purified bovine (IV)NC1 as 
the solid phase antigen, with confirmation of antibody spec-
ificity for recombinant human 3(IV)NC1. ANCAs were 
negatively-screened by both indirect immunofluorescence 
assay (Euroimmun) and antigen-specific ELISA against 
myeloperoxidase (MPO) and proteinase 3 (PR3). Patients 
with other coexisting renal diseases were excluded. Clinical 
and pathological parameters were collected from medical 
records at the time of presentation and during follow-up. 
Biopsy samples were obtained before immunosuppressive 
treatment. The experimental protocols complied with the 
Declaration of Helsinki and approved by the ethics com-
mittee of Peking University First Hospital. Written in-
formed consent was obtained from each participant. 
Routine renal histopathology 
Renal biopsy was performed at the time of diagnosis. For 
direct immunofluorescence measurements, frozen sections 
were examined by a fluorescent microscopy (Nikon, Japan) 
after staining with fluorescein isothiocyanate (FITC)-  
conjugated antibodies specific for human IgG, IgM, IgA, 
C3c, C1q, fibrinogen, and albumin (Dako, Denmark). For 
light microscopy observations, paraffinized sections were 
stained with hematoxylin and eosin, periodic acid-Schiff, 
periodic acid-silver methenamine, and Masson’s trichrome 
staining. For electron microscopy observations, the biopsy 
materials were fixed in glutaraldehyde, post-fixed in osmi-
um tetroxide, dehydrated in graded acetone, and embedded 
in Epon 812 resin (Zhongshan Golden Bridge Biotechnolo-
gy, China). Ultrathin sections were stained with uranyl ace-
tate and lead citrate, and examined by a JEM-1230 trans-
mission electron microscope (JEOL, Japan).  
Renal immunohistochemistry 
To assess the cellular infiltration in renal tissues, immuno-
histochemical staining was performed for CD3, CD4, CD8, 
IL-17, foxp3, and CD68 using the primary antibodies listed 
in Table 5. Four-micron formaldehyde-fixed paraffin- 
embedded renal tissue sections were deparaffinized in  
xylene-ethanol, rehydrated in graded alcohol, and immersed 
in freshly prepared 3% hydrogen peroxide in methanol so-
lution for 10 min at room temperature to quench endoge-
nous peroxidase activity. After washing in phosphate buff-
ered saline (PBS), the sections were immersed in citric acid 
buffer (0.01 mol L1, pH 6.0). The sections were then treat-
ed at 800 Watts by microwave for 2 min and subsequently 
at 200 Watts for 8 min for antigen retrieval. To block 
non-specific staining, the sections were incubated with 3% 
bovine serum albumin in PBS at 37°C for 30 min. The pri-
mary antibodies were added to each section and incubated 
overnight at 4°C. EnVision horseradish peroxidase (HRP) 
(Dako A/S, Denmark) was used as a detection system. This 
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Table 5  Primary antibodies used for immunohistochemistry. 
Markers Cells  Specificity Dilution Source 
CD3 T lymphocytes rabbit anti-CD3 monoclonal antibody 1:300 Lab Vision, Newcastle, UK  
CD4 Helper T cells  rabbit anti-CD4 monoclonal antibody 1:100 Zhongshan Golden Bridge Biotechnology, Beijing,  China 
CD8 Cytotoxic T cells  rabbit anti-CD8 monoclonal antibody 1:100 Lab Vision, Newcastle, UK 
Foxp3 Regulatory T cells mouse anti-Foxp3 monoclonal antibody 1:100 Abcam, Cambridge, UK 
IL-17 
IL-17-producing cells 
(especially Th17 cells) 
goat anti-IL-17 polyclonal antibody 1:100 R&D, Wiesbaden, Germany 
CD68 Macrophages mouse anti-CD68 monoclonal antibody 1:500 Abcam, Cambridge, UK 
 
method uses an avidin-free, two-step indirect method with 
anti-rabbit, anti-mouse, and anti-goat immunoglobulin con-
jugated with HRP as secondary antibodies. The sections 
were incubated with the secondary antibodies for 30 min at 
37°C before being developed in fresh hydrogen peroxide 
plus 3-3-diaminobenzidine tetrahydrochloride solution for  
2 min. Finally, the sections were counterstained with peri-
odic acid-Schiff and hematoxylin, and dehydrated using 
graded alcohols and xylene.  
Appropriate dilutions of the primary and secondary anti-
bodies were determined on tissue sections of human lymph 
nodes and tonsils. The lymph node sections were used as 
positive controls. Renal tissues obtained from the normal 
part of a nephrectomized kidney due to renal carcinoma 
were used as negative controls. They were considered nor-
mal, as indicated by light microscopy, immunofluorescence 
and electron microscopy. The primary antibodies were re-
placed with normal rabbit or mouse IgG as blank controls.  
Tissue analysis and evaluation of positive stained cells in 
histopathology 
Two pathologists independently evaluated all kidney sec-
tions and were blind to the clinical data. Differences be-
tween the evaluations for the same sections were resolved 
by reviewing the sections and reaching consensus conclu-
sions. 
The number of glomeruli with lesions was expressed as 
the percentage of injured glomeruli in all the glomeruli in 
renal biopsy tissues. Each glomerulus was separately scored 
for the presence of fibrinoid necroses, crescents (i.e., cellu-
lar, fibrocellular, and fibrous) and glomerular sclerosis. The 
periglomerular and interstitial areas were defined as previ-
ously described (Couzi et al., 2007). Briefly, the area be-
tween the Bowman’s capsule and adjacent tubules was de-
fined as the periglomerular area. The peritubular area was 
defined as the interstitial area excluding the periglomerular 
area. 
The numbers of stained cells in the glomerular and peri-
glomerular areas were counted in each glomerulus and ex-
pressed as the number of cells per glomerular cross-section 
(gcs). Interstitial infiltrating cells were counted in 10 fields 
at 400× magnification, referring to an area of 0.069 mm2 
field1. The results were expressed as the number of positive 
cells per square millimeter.  
Statistical analysis 
Differences in quantitative data were assessed using Stu-
dent’s t test (for normally distributed data), or Mann- 
Whitney U test or Wilcoxon 1-sample test (for non- 
normally distributed data). Differences in semi-quantitative 
data were evaluated using Kruskal Wallis H one-way analy-
sis and Mann-Whitney U test. Differences in qualitative 
data were compared using Chi square tests. Pearson’s cor-
relation test was used to measure the correlation between 
two normally distributed variables. Spearman’s correlation 
test was used to measure the correlation between two 
non-normally distributed variables or one normally and one 
non-normally distributed variables. All statistical analyses 
were two-tailed, and P<0.05 was considered significant. 
SPSS 13.0 (SPSS, USA) was employed. 
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